Loading
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.
Latest quote
$18.22
+$0.18 · +1.00%
After-hours
$18.22
$0.00 · 0.00%
Oct 8, 4:55 PM ET
Regular session · ET · Market data may be delayed.
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.
Day range
Current $18.22
52-week range
Current $18.22
Regular session · ET · Market data may be delayed.
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.
Day range
Current $18.22
52-week range
Current $18.22
Third-party consensus; not a GoAI recommendation.
Average target
$60.00
229.31% upsideFunds reporting this stock among their holdings, ordered by reported position size.
iShares Russell 2000 ETFIWM5.64M0.01%78.56B USD0.19%$277.57-0.05%
Vanguard Morningstar Total Stock Market ETFVTI1.62M0.00%2.3T USD0.03%$379.56-0.39%
iShares Russell 2000 Growth ETFIWO1.24M0.01%14.25B USD0.24%$353.47-0.53%
Schwab U.S. Small-Cap ETFSCHA1.12M0.01%21.7B USD0.03%$32.66+0.15%
iShares Micro-Cap ETFIWC695.48K0.05%1.33B USD0.60%$182.79-0.31%
Vanguard Extended Market ETFVXF604.75K0.00%95.4B USD0.05%$233.13-0.15%
Vanguard Russell 2000 ETFVTWO207.59K0.00%18B USD0.06%$112.1-0.10%
Schwab U.S. Broad Market ETFSCHB150.59K0.00%45.25B USD0.03%$29.73-0.40%iShares Russell 2000 ETFIWMVanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 Growth ETFIWOSchwab U.S. Small-Cap ETFSCHAiShares Micro-Cap ETFIWCVanguard Extended Market ETFVXFVanguard Russell 2000 ETFVTWOSchwab U.S. Broad Market ETFSCHBAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
